Akshat Jain: Bridging Innovation and Access in Hematology at EHGCON 2026
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn:
“India: A Breath of Fresh Air in Kolkata
It was an absolute honor to deliver the Keynote Address at the Eastern Hematology Summit – EHGCON 2026.
The scientific discourse with India’s leading academicians and hematologists was outstanding — filled with passion, expertise, and a shared commitment to advancing care for patients with blood disorders and hematological malignancies.
Yet, as we celebrate these meaningful conversations, one reality continues to trouble me deeply:
Despite the presence of world-class expertise across the country, millions of patients in India still face unacceptable delays in accessing newer therapies. The future of these patients lies in the hands of dedicated clinicians who often have to ‘scrape the barrel’ to bridge the gap.
We must do better — faster diagnosis, equitable access, and stronger collaboration between academia, industry, and policymakers are not just aspirations, but necessities.
Grateful to be part of this important movement & the new deep meaningful collaborations that were inked at this summit.”
Find more posts featuring Akshat Jain on Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering